Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.

Akahane K, Murakami Y, Kagami K, Abe M, Harama D, Shinohara T, Watanabe A, Goi K, Nishi R, Yamauchi T, Kimura S, Takita J, Look AT, Minegishi M, Sugita K, Inukai T.

Hematol Oncol. 2019 Oct;37(4):516-519. doi: 10.1002/hon.2654. Epub 2019 Aug 2. No abstract available.

PMID:
31335977
2.

Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.

Watanabe A, Inukai T, Kagami K, Abe M, Takagi M, Fukushima T, Fukushima H, Nanmoku T, Terui K, Ito T, Toki T, Ito E, Fujimura J, Goto H, Endo M, Look T, Kamps M, Minegishi M, Takita J, Inaba T, Takahashi H, Ohara A, Harama D, Shinohara T, Somazu S, Oshiro H, Akahane K, Goi K, Sugita K.

Cancer Med. 2019 Sep;8(11):5274-5288. doi: 10.1002/cam4.2356. Epub 2019 Jul 15.

3.

Successful hematopoietic stem cell transplantation from an HLA-mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases.

Akahane K, Watanabe A, Furuichi Y, Somazu S, Oshiro H, Goi K, Sakashita K, Muramatsu H, Hama A, Takahashi Y, Koike K, Kojima S, Sugita K, Inukai T.

Pediatr Transplant. 2019 May;23(3):e13378. doi: 10.1111/petr.13378. Epub 2019 Feb 20.

PMID:
30786117
4.

Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.

Ando N, Furuichi Y, Kasai S, Tamai M, Harama D, Kagami K, Abe M, Goi K, Inukai T, Sugita K.

Leuk Res. 2018 Dec;75:36-44. doi: 10.1016/j.leukres.2018.11.001. Epub 2018 Nov 3.

PMID:
30453100
5.

Modification of cellular and humoral immunity by somatically reverted T cells in X-linked lymphoproliferative syndrome type 1.

Hoshino A, Yang X, Tanita K, Yoshida K, Ono T, Nishida N, Okuno Y, Kanzaki T, Goi K, Fujino H, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H.

J Allergy Clin Immunol. 2019 Jan;143(1):421-424.e11. doi: 10.1016/j.jaci.2018.07.044. Epub 2018 Oct 17. No abstract available.

PMID:
30342818
6.

De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.

Toki T, Yoshida K, Wang R, Nakamura S, Maekawa T, Goi K, Katoh MC, Mizuno S, Sugiyama F, Kanezaki R, Uechi T, Nakajima Y, Sato Y, Okuno Y, Sato-Otsubo A, Shiozawa Y, Kataoka K, Shiraishi Y, Sanada M, Chiba K, Tanaka H, Terui K, Sato T, Kamio T, Sakaguchi H, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Kanno H, Miyano S, Kojima S, Ishiguro A, Sugita K, Kenmochi N, Takahashi S, Eto K, Ogawa S, Ito E.

Am J Hum Genet. 2018 Sep 6;103(3):440-447. doi: 10.1016/j.ajhg.2018.07.020. Epub 2018 Aug 23.

7.

Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors.

Nakamura M, Wu L, Griffin JD, Kojika S, Goi K, Inukai T, Sugita K.

Leuk Res. 2018 Sep;72:34-44. doi: 10.1016/j.leukres.2018.07.022. Epub 2018 Jul 30.

8.

T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system.

Tamai M, Inukai T, Kojika S, Abe M, Kagami K, Harama D, Shinohara T, Watanabe A, Oshiro H, Akahane K, Goi K, Sugihara E, Nakada S, Sugita K.

Sci Rep. 2018 Jul 2;8(1):9966. doi: 10.1038/s41598-018-27767-6.

9.

Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

Huang M, Inukai T, Miyake K, Tanaka Y, Kagami K, Abe M, Goto H, Minegishi M, Iwamoto S, Sugihara E, Watanabe A, Somazu S, Shinohara T, Oshiro H, Akahane K, Goi K, Sugita K.

Cancer Med. 2018 Apr;7(4):1297-1316. doi: 10.1002/cam4.1323. Epub 2018 Feb 23.

10.

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.

Takahashi K, Inukai T, Imamura T, Yano M, Tomoyasu C, Lucas DM, Nemoto A, Sato H, Huang M, Abe M, Kagami K, Shinohara T, Watanabe A, Somazu S, Oshiro H, Akahane K, Goi K, Kikuchi J, Furukawa Y, Goto H, Minegishi M, Iwamoto S, Sugita K.

PLoS One. 2017 Dec 13;12(12):e0188680. doi: 10.1371/journal.pone.0188680. eCollection 2017.

11.

TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.

Tamai M, Furuichi Y, Kasai S, Ando N, Harama D, Goi K, Inukai T, Kagami K, Abe M, Ichikawa H, Sugita K.

Leuk Res. 2017 Oct;61:68-76. doi: 10.1016/j.leukres.2017.08.013. Epub 2017 Sep 14.

PMID:
28917156
12.

Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B-cell precursor acute lymphoblastic leukaemia.

Huang M, Inukai T, Kagami K, Abe M, Shinohara T, Watanabe A, Somazu S, Oshiro H, Goi K, Goto H, Minegishi M, Iwamoto S, Urayama KY, Sugita K.

Hematol Oncol. 2018 Feb;36(1):245-251. doi: 10.1002/hon.2471. Epub 2017 Aug 29.

PMID:
28850694
13.

Autologous Stem Cell Rescue for Graft Failure of Second Allogeneic Stem Cell Transplant After Engraftment of Primary Allogeneic Transplant.

Watanabe A, Inukai T, Akahane K, Somazu S, Oshiro H, Goi K, Koizumi K, Harii N, Matsuda K, Sugita K.

Exp Clin Transplant. 2019 Apr;17(2):281-283. doi: 10.6002/ect.2016.0315. Epub 2017 Jul 31.

14.

Lack of association between deletion polymorphism of BIM gene and in vitro drug sensitivity in B-cell precursor acute lymphoblastic leukemia.

Huang M, Miyake K, Kagami K, Abe M, Shinohara T, Watanabe A, Somazu S, Oshiro H, Goi K, Goto H, Minegishi M, Iwamoto S, Kiyokawa N, Sugita K, Inukai T.

Leuk Res. 2017 Sep;60:24-30. doi: 10.1016/j.leukres.2017.06.003. Epub 2017 Jun 4.

PMID:
28641145
15.

Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.

Kasai S, Furuichi Y, Ando N, Kagami K, Abe M, Nakane T, Goi K, Inukai T, Saitoh S, Ohno S, Okazaki S, Nagano O, Saya H, Sugita K.

Cell Death Dis. 2017 Jun 1;8(6):e2857. doi: 10.1038/cddis.2017.249.

16.

Erythrophagocytosis in T-cell type acute lymphoblastic leukaemia with near-tetraploidy.

Watanabe A, Akahane K, Somazu S, Oshiro H, Goi K, Miyachi H, Kiyokawa N, Inukai T, Sugita K.

J Clin Pathol. 2016 Dec;69(12):1129-1132. doi: 10.1136/jclinpath-2016-203915. Epub 2016 Aug 12. No abstract available.

PMID:
27520437
17.

Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia.

Nemoto A, Saida S, Kato I, Kikuchi J, Furukawa Y, Maeda Y, Akahane K, Honna-Oshiro H, Goi K, Kagami K, Kimura S, Sato Y, Okabe S, Niwa A, Watanabe K, Nakahata T, Heike T, Sugita K, Inukai T.

Mol Cancer Ther. 2016 Jan;15(1):94-105. doi: 10.1158/1535-7163.MCT-14-1065. Epub 2015 Dec 4.

18.

Analyses of Genetic and Clinical Parameters for Screening Patients With Inherited Thrombocytopenia with Small or Normal-Sized Platelets.

Ouchi-Uchiyama M, Sasahara Y, Kikuchi A, Goi K, Nakane T, Ikeno M, Noguchi Y, Uike N, Miyajima Y, Matsubara K, Koh K, Sugita K, Imaizumi M, Kure S.

Pediatr Blood Cancer. 2015 Dec;62(12):2082-8. doi: 10.1002/pbc.25668. Epub 2015 Jul 14.

PMID:
26175287
19.

Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.

Oshiro H, Goi K, Akahane K, Inukai T, Sugita K.

Pediatr Int. 2015 Apr;57(2):e27-9. doi: 10.1111/ped.12522.

PMID:
25868955
20.

Low-loss partial rib polarization rotator consisting only of silicon core and silica cladding.

Goi K, Oka A, Kusaka H, Ogawa K, Liow TY, Tu X, Lo GQ, Kwong DL.

Opt Lett. 2015 Apr 1;40(7):1410-3. doi: 10.1364/OL.40.001410.

PMID:
25831345
21.

Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia.

Wang R, Yoshida K, Toki T, Sawada T, Uechi T, Okuno Y, Sato-Otsubo A, Kudo K, Kamimaki I, Kanezaki R, Shiraishi Y, Chiba K, Tanaka H, Terui K, Sato T, Iribe Y, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Hara J, Goi K, Matsubara K, Koike K, Ishiguro A, Okamoto Y, Watanabe K, Kanno H, Kojima S, Miyano S, Kenmochi N, Ogawa S, Ito E.

Br J Haematol. 2015 Mar;168(6):854-64. doi: 10.1111/bjh.13229. Epub 2014 Nov 25.

PMID:
25424902
22.

Pre-B-cell acute lymphoblastic leukemia in a boy with hereditary multiple exostoses caused by EXT1 deletion.

Nakane T, Goi K, Oshiro H, Kobayashi C, Sato H, Kubota T, Sugita K.

Pediatr Hematol Oncol. 2014 Oct;31(7):667-9. doi: 10.3109/08880018.2014.935538. Epub 2014 Aug 12. No abstract available.

PMID:
25116165
23.

Low-loss high-speed silicon IQ modulator for QPSK/DQPSK in C and L bands.

Goi K, Oka A, Kusaka H, Terada Y, Ogawa K, Liow TY, Tu X, Lo GQ, Kwong DL.

Opt Express. 2014 May 5;22(9):10703-9. doi: 10.1364/OE.22.010703.

PMID:
24921771
24.

B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID.

Kumaki S, Sasahara Y, Kamachi Y, Muramatsu H, Morio T, Goi K, Sugita K, Urabe T, Takada H, Kojima S, Tsuchiya S, Hara T.

Int J Hematol. 2013 Sep;98(3):355-60. doi: 10.1007/s12185-013-1408-7. Epub 2013 Aug 17.

PMID:
23955111
25.

11-Gb/s 80-km transmission performance of zero-chirp silicon Mach-Zehnder modulator.

Goi K, Oda K, Kusaka H, Terada Y, Ogawa K, Liow TY, Tu X, Lo GQ, Kwong DL.

Opt Express. 2012 Dec 10;20(26):B350-6. doi: 10.1364/OE.20.00B350.

PMID:
23262872
26.

Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias.

Nemoto A, Inukai T, Uno K, Kiyokawa N, Miyagawa Y, Takahashi K, Sato H, Akahane K, Hirose K, Honna-Oshiro H, Goi K, Kagami K, Nakazawa S, Fujimoto J, Inaba T, Sugita K.

Leuk Res. 2013 Jan;37(1):93-101. doi: 10.1016/j.leukres.2012.10.001. Epub 2012 Oct 23.

PMID:
23099235
27.

Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.

Zhang X, Inukai T, Hirose K, Akahane K, Kuroda I, Honna-Oshiro H, Kagami K, Goi K, Nakamura K, Kobayashi M, Endo M, Yagita H, Kurosawa H, Thomas Look A, Honda H, Inaba T, Nakazawa S, Sugita K.

Leukemia. 2012 Dec;26(12):2483-93. doi: 10.1038/leu.2012.139. Epub 2012 May 30.

PMID:
22743623
28.

BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.

Kuroda I, Inukai T, Zhang X, Kikuchi J, Furukawa Y, Nemoto A, Akahane K, Hirose K, Honna-Oshiro H, Goi K, Kagami K, Yagita H, Tauchi T, Maeda Y, Sugita K.

Oncogene. 2013 Mar 28;32(13):1670-81. doi: 10.1038/onc.2012.186. Epub 2012 Jun 4.

PMID:
22665066
29.

Silicon Mach-Zehnder modulator of extinction ratio beyond 10 dB at 10.0-12.5 Gbps.

Ogawa K, Goi K, Tan YT, Liow TY, Tu X, Fang Q, Lo GQ, Kwong DL.

Opt Express. 2011 Dec 12;19(26):B26-31. doi: 10.1364/OE.19.000B26.

PMID:
22274027
30.

Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia.

Kuramitsu M, Sato-Otsubo A, Morio T, Takagi M, Toki T, Terui K, Wang R, Kanno H, Ohga S, Ohara A, Kojima S, Kitoh T, Goi K, Kudo K, Matsubayashi T, Mizue N, Ozeki M, Masumi A, Momose H, Takizawa K, Mizukami T, Yamaguchi K, Ogawa S, Ito E, Hamaguchi I.

Blood. 2012 Mar 8;119(10):2376-84. doi: 10.1182/blood-2011-07-368662. Epub 2012 Jan 18.

PMID:
22262766
31.

Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis.

Zhang X, Inukai T, Akahane K, Hirose K, Kuroda I, Honna H, Goi K, Kagami K, Tauchi T, Yagita H, Sugita K.

Leuk Res. 2011 Jul;35(7):940-9. doi: 10.1016/j.leukres.2011.03.016. Epub 2011 Apr 3.

PMID:
21466892
32.

Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN.

Goi K, Inukai T, Honna H, Akahane K, Hirose K, Kuroda I, Hasuda N, Koshizuka K, Takano K, Sugita K.

Bone Marrow Transplant. 2011 Jun;46(6):835-9. doi: 10.1038/bmt.2010.191. Epub 2010 Aug 9.

PMID:
20697365
33.

Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.

Akahane K, Inukai T, Zhang X, Hirose K, Kuroda I, Goi K, Honna H, Kagami K, Nakazawa S, Endo K, Kubota T, Yagita H, Koyama-Okazaki T, Sugita K.

Exp Hematol. 2010 Oct;38(10):885-95. doi: 10.1016/j.exphem.2010.06.014. Epub 2010 Jul 27.

PMID:
20670671
34.

A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines.

Inukai T, Zhang X, Kameyama T, Suzuki Y, Yoshikawa K, Kuroda I, Nemoto A, Akahane K, Sato H, Goi K, Nakamoto K, Hamada J, Tada M, Moriuchi T, Sugita K.

Am J Hematol. 2010 Jul;85(7):535-7. doi: 10.1002/ajh.21738. No abstract available.

35.

Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).

Hirose K, Inukai T, Kikuchi J, Furukawa Y, Ikawa T, Kawamoto H, Oram SH, Göttgens B, Kiyokawa N, Miyagawa Y, Okita H, Akahane K, Zhang X, Kuroda I, Honna H, Kagami K, Goi K, Kurosawa H, Look AT, Matsui H, Inaba T, Sugita K.

Blood. 2010 Aug 12;116(6):962-70. doi: 10.1182/blood-2009-09-244673. Epub 2010 Jun 2.

PMID:
20519628
36.

Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients.

Nabhan SK, Bitencourt MA, Duval M, Abecasis M, Dufour C, Boudjedir K, Rocha V, Socié G, Passweg J, Goi K, Sanders J, Snowden J, Yabe H, Pasquini R, Gluckman E; Aplastic Anaemia Working Party, EBMT.

Haematologica. 2010 Oct;95(10):1783-7. doi: 10.3324/haematol.2010.023929. Epub 2010 May 21.

37.

[Chronic graft-versus-host disease with multiple serositis after bone marrow transplantation from non-inherited maternal antigen-complementary sibling donor].

Akahane K, Inukai T, Nemoto A, Kuroda I, Minai A, Hirose K, Honna H, Goi K, Sugita K.

Rinsho Ketsueki. 2010 Feb;51(2):132-7. Japanese.

PMID:
20379105
38.

New design and analysis of Bragg grating waveguides.

Ogawa K, Guan N, Goi K, Sakuma K, Tan YT, Yu MB, Teo SH, Lo GQ.

Opt Express. 2010 Feb 1;18(3):2002-9. doi: 10.1364/OE.18.002002.

PMID:
20174030
39.

Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.

Akahane K, Inukai T, Inaba T, Kurosawa H, Look AT, Kiyokawa N, Fujimoto J, Goto H, Endo M, Zhang X, Hirose K, Kuroda I, Honna H, Kagami K, Goi K, Nakazawa S, Sugita K.

Leukemia. 2010 Apr;24(4):865-9. doi: 10.1038/leu.2010.8. Epub 2010 Feb 11. No abstract available.

PMID:
20147975
40.

Early lineage switch in an infant acute lymphoblastic leukemia.

Sakaki H, Kanegane H, Nomura K, Goi K, Sugita K, Miura M, Ishii E, Miyawaki T.

Int J Hematol. 2009 Dec;90(5):653-655. doi: 10.1007/s12185-009-0446-7. Epub 2009 Nov 21. No abstract available.

PMID:
19936875
41.

Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT.

Inukai T, Goi K, Tezuka T, Uno K, Nemoto A, Takahashi K, Sato H, Akahane K, Hirose K, Honna H, Kuroda I, Kagami K, Nakamoto K, Taniguchi K, Nakazawa S, Sugita K.

Bone Marrow Transplant. 2009 Feb;43(3):229-35. doi: 10.1038/bmt.2008.311. Epub 2008 Sep 22.

PMID:
18806835
42.

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.

Furuichi Y, Goi K, Inukai T, Sato H, Nemoto A, Takahashi K, Akahane K, Hirose K, Honna H, Kuroda I, Zhang X, Kagami K, Hayashi Y, Harigaya K, Nakazawa S, Sugita K.

Cancer Res. 2007 Oct 15;67(20):9852-61.

43.

Monitoring neutrophil engraftment in allogeneic stem cell transplantation by flow cytometric analysis of neutrophil-specific antigens NA1 and NA2.

Inukai T, Uno K, Taniguchi K, Goi K, Tezuka T, Nemoto A, Takahashi K, Sato H, Akahane K, Hirose K, Honna H, Kagami K, Hiraoka A, Tanihiro M, Nakazawa S, Sugita K.

Br J Haematol. 2007 Oct;139(2):280-3. Epub 2007 Aug 30.

PMID:
17764467
44.

Revision of the cytological diagnosis of CNS relapse into aseptic meningitis in a patient with TEL-AML1+ acute lymphoblastic leukaemia by FISH analysis of mononuclear cells in cerebrospinal fluid.

Inukai T, Akahane K, Nemoto A, Kuroda I, Noguchi S, Hirose K, Honna H, Goi K, Kondo T, Iwasa S, Murata S, Kato R, Nakazawa S, Sugita K.

Histopathology. 2007 Jun;50(7):947-9. No abstract available.

PMID:
17543087
45.

Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.

Tsuzuki S, Karnan S, Horibe K, Matsumoto K, Kato K, Inukai T, Goi K, Sugita K, Nakazawa S, Kasugai Y, Ueda R, Seto M.

Cancer Sci. 2007 May;98(5):698-706. Epub 2007 Mar 21.

46.

Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.

Inukai T, Hirose K, Inaba T, Kurosawa H, Hama A, Inada H, Chin M, Nagatoshi Y, Ohtsuka Y, Oda M, Goto H, Endo M, Morimoto A, Imaizumi M, Kawamura N, Miyajima Y, Ohtake M, Miyaji R, Saito M, Tawa A, Yanai F, Goi K, Nakazawa S, Sugita K.

Leukemia. 2007 Feb;21(2):288-96. Epub 2006 Dec 21.

PMID:
17183364
47.

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity.

Inukai T, Zhang X, Goto M, Hirose K, Uno K, Akahane K, Nemoto A, Goi K, Sato H, Takahashi K, Honna H, Kagami K, Nakamoto K, Yagita H, Okumura K, Koyama-Okazaki T, Nakazawa S, Sugita K.

Leukemia. 2006 Dec;20(12):2119-29. Epub 2006 Oct 26.

PMID:
17066095
48.

Natural pregnancy and delivery after allogeneic bone marrow transplantation in a Fanconi anaemia patient.

Goi K, Sugita K, Nakamura M, Inukai T, Honna H, Hirose K, Kuroda I, Hoshi K, Nakazawa S.

Br J Haematol. 2006 Nov;135(3):410-1. Epub 2006 Sep 15. No abstract available.

PMID:
16978220
49.

Clonotypic analysis of acute lymphoblastic leukemia with a double TEL-AML1 fusion at onset and relapse.

Inukai T, Yokota S, Okamoto T, Nemoto A, Akahane K, Takahashi K, Sato H, Goi K, Nakazawa S, Sugita K.

Leukemia. 2006 Feb;20(2):363-5. No abstract available.

PMID:
16357830
50.

A successful case of allogeneic bone marrow transplantation for osteosarcoma with multiple metastases of lung and bone.

Goi K, Sugita K, Tezuka T, Sato H, Uno K, Inukai T, Hamada Y, Nakazawa S.

Bone Marrow Transplant. 2006 Jan;37(1):115-6. No abstract available.

PMID:
16258530

Supplemental Content

Support Center